Literature DB >> 6311564

The measurement of superoxide anion production by granulocytes In whole blood. A clinical test for the evaluation of phagocyte function and serum opsonic capacity.

P Bellavite, P Dri, V Della Bianca, M C Serra.   

Abstract

The paper reports a simple, sensitive and time-saving procedure for the assay of the function of the phagocytes on microsamples of whole blood. The method consists in the evaluation of the stimulation of superoxide anion (O-2) production (as superoxide dismutase-sensitive cytochrome c reduction) by leukocytes in whole blood challenged with (a) phagocytosable particles (opsonized zymosan); (b) particles that become phagocytosable by virtue of the opsonizing capacity of the plasma of blood samples (zymosan); and (c) a soluble agent such as phorbol myristate acetate. Preliminary studies indicate that this procedure can be used as a routine test because it enables information to be obtained about the respiratory responsiveness of phagocytes and about cellular and humoral defects of phagocytosis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6311564     DOI: 10.1111/j.1365-2362.1983.tb00114.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  16 in total

1.  Polymorphonuclear neutrophils function in splenectomized patients.

Authors:  H Wysocki; B Wierusz-Wysocka; H Karoń; J Dotka; A Wykretowicz; A Szczepanik; R Klimas
Journal:  Clin Exp Immunol       Date:  1989-03       Impact factor: 4.330

2.  Activation of mouse macrophages causes no change in expression and function of phorbol diesters' receptors, but is accompanied by alterations in the activity and kinetic parameters of NADPH oxidase.

Authors:  G Berton; M Cassatella; G Cabrini; F Rossi
Journal:  Immunology       Date:  1985-02       Impact factor: 7.397

3.  Superoxide anion production by circulating polymorphonuclear leucocytes in rheumatoid arthritis.

Authors:  A Cencetti; M De Martino; E Graziani; S Maddali Bongi; C Palermo; E Pavari; M Zoppi
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

4.  Monitoring of cytosolic free Ca2+ in C5a-stimulated neutrophils: loss of receptor-modulated Ca2+ stores and Ca2+ uptake in granule-free cytoplasts.

Authors:  R Gennaro; T Pozzan; D Romeo
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

5.  Relationship between a common variant in the fatty acid desaturase (FADS) cluster and eicosanoid generation in humans.

Authors:  Austin G Hester; Robert C Murphy; Charis J Uhlson; Priscilla Ivester; Tammy C Lee; Susan Sergeant; Leslie R Miller; Timothy D Howard; Rasika A Mathias; Floyd H Chilton
Journal:  J Biol Chem       Date:  2014-06-24       Impact factor: 5.157

6.  Interferon-gamma inhibits interleukin-8 production by human polymorphonuclear leucocytes.

Authors:  M A Cassatella; I Guasparri; M Ceska; F Bazzoni; F Rossi
Journal:  Immunology       Date:  1993-02       Impact factor: 7.397

7.  Tumor necrosis factor and immune interferon synergistically induce cytochrome b-245 heavy-chain gene expression and nicotinamide-adenine dinucleotide phosphate hydrogenase oxidase in human leukemic myeloid cells.

Authors:  M A Cassatella; L Hartman; B Perussia; G Trinchieri
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

8.  Chronic granulomatous disease in two sisters.

Authors:  R D'Amelio; P Bellavite; P Bianco; P de Sole; S Le Moli; S Lippa; R Seminara; B Vercelli; F Rossi; G Rocchi
Journal:  J Clin Immunol       Date:  1984-05       Impact factor: 8.317

9.  Effects of ozone on some biological activities of cells in vitro.

Authors:  V Cardile; X Jiang; A Russo; F Casella; M Renis; M Bindoni
Journal:  Cell Biol Toxicol       Date:  1995-02       Impact factor: 6.691

10.  In vivo activation of neutrophil function in hamsters by recombinant human granulocyte colony-stimulating factor.

Authors:  A M Cohen; D K Hines; E S Korach; B J Ratzkin
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.